Task Force #4—adherence issues and behavior changes: achieving a long-term solution
- 21 August 2002
- journal article
- review article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 40 (4), 630-640
- https://doi.org/10.1016/s0735-1097(02)02078-8
Abstract
No abstract availableThis publication has 73 references indexed in Scilit:
- Usefulness of providing physicians the results of risk factor assessments and treatment recommendations at discharge after coronary artery bypass graftingThe American Journal of Cardiology, 2000
- The Lipid Treatment Assessment Project (L-TAP)Archives of Internal Medicine, 2000
- Sex Bias and Underutilization of Lipid-Lowering Therapy in Patients With Coronary Artery Disease at Academic Medical Centers in the United States and CanadaArchives of Internal Medicine, 2000
- Use of Aspirin, β-Blockers, and Lipid-Lowering Medications Before Recurrent Acute Myocardial InfarctionArchives of Internal Medicine, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Physician Noncompliance With the 1993 National Cholesterol Education Program (NCEP-ATPII) GuidelinesCirculation, 1998
- Use of lipid-lowering medication in patients with acute myocardial infarction (Worcester Heart Attack Study).The American Journal of Cardiology, 1997
- Health beliefs, personality, and adherence in hemodialysis patients: An interactional perspectiveAnnals of Behavioral Medicine, 1997
- The Multilevel Compliance Challenge: Recommendations for a Call to ActionCirculation, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996